Skip to content

Clinical trials

Completed Multiple Sclerosis, Chronic Progressive trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Chronic Progressive Status: Completed Country / region: Germany Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20112
20121
20141
20152
20162
20171
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genzyme, a Sanofi Company2
Novartis Pharmaceuticals2
Sanofi2
AB Science1
Bayer1
Eli Lilly and Company1
Genentech, Inc.1
Hoffmann-La Roche1
Teva Branded Pharmaceutical Products R&D, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Chronic Progressive12
Multiple Sclerosis3
COVID-191
Carcinoma in Situ1
Multiple Sclerosis, Relapsing-Remitting1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.